SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0001188112-11-003256
Filing Date
2011-11-15
Accepted
2011-11-15 16:12:19
Documents
5
Filing Date Changed
2011-11-15
Group Members
DANIEL J. DONOGHUEDISCOVERY GROUP I LLCMICHAEL R. MURPHY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D (AMENDMENT NO. 2) t71971_sc13da.htm SC 13D/A 152623
2 EXHIBIT 1 ex1.htm EX-1 30973
3 EXHIBIT 2 ex2.htm EX-2 15185
4 EXHIBIT 3 ex3.htm EX-3 10763
5 EXHIBIT 4 ex4.htm EX-4 9713
  Complete submission text file 0001188112-11-003256.txt   221055
Mailing Address C/O DISCOVERY GROUP I, LLC 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606
Business Address C/O DISCOVERY GROUP I, LLC 191 N. WACKER DRIVE SUITE 1685 CHICAGO IL 60606 312-265-9600
DISCOVERY EQUITY PARTNERS, LP (Filed by) CIK: 0001258542 (see all company filings)

IRS No.: 300075082 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806
Business Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806 562-628-1007
Obagi Medical Products, Inc. (Subject) CIK: 0001375247 (see all company filings)

IRS No.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82589 | Film No.: 111207391
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1